Edward Schnipper is listed as a director on 6 SEC Form D filings by 2 issuers between Jan 2014 and Feb 2015: Neos Therapeutics, Inc. (Grand Prairie, TX — pharmaceuticals — 2014–2015; $24.2M reported sold to 57 investors) and BlueCava, Inc. (Irvine, CA — other technology — 2014; $10.1M reported sold to 9 investors).
What this means 2 separate companies raised money with this person listed as director. Across those companies the filings report $34.3M sold in total.
Listed alongside Arlen Ewart (6 shared filings), Asif Mughal (6 shared filings), Carolyn Sikes (6 shared filings), Dorothy Engelking (6 shared filings), Greg Robitaille (6 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Edward. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for Edward Schnipper and found 6 differences, 1 worth asking the sponsor about: Edward Schnipper is no longer listed on the Feb 25, 2014 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.